Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.40
-0.19 (-2.50%)
Nov 7, 2025, 11:29 AM EST - Market open
Novavax Stock Forecast
Stock Price Forecast
The 7 analysts that cover Novavax stock have a consensus rating of "Hold" and an average price target of $10.71, which forecasts a 44.73% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $19.
Price Target: $10.71 (+44.73%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Novavax stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 1 | 0 | 0 | 0 | 1 |
| Sell | 1 | 1 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 5 | 6 | 7 | 7 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | -5.41% | Nov 4, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $18 | Buy | Initiates | $18 | +143.24% | Oct 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +48.65% | Oct 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +35.14% | Aug 28, 2025 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $9 → $7 | Hold → Sell | Downgrades | $9 → $7 | -5.41% | Aug 20, 2025 |
Financial Forecast
Revenue This Year
1.09B
from 682.16M
Increased by 59.49%
Revenue Next Year
449.89M
from 1.09B
Decreased by -58.65%
EPS This Year
2.33
from -1.23
EPS Next Year
0.22
from 2.33
Decreased by -90.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.2B | 969.4M | |||
| Avg | 1.1B | 449.9M | |||
| Low | 1,000.0M | 285.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 80.7% | -10.9% | |||
| Avg | 59.5% | -58.6% | |||
| Low | 46.6% | -73.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.13 | 3.03 | |||
| Avg | 2.33 | 0.22 | |||
| Low | 1.17 | -0.64 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 30.4% | |||
| Avg | - | -90.5% | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.